2018.0: Sunday, October 21, 2001: 11:30 AM-3:00 PM

Oral Session

Update on Medicare and Prescription Drug Issues for the New Millennium

See individual abstracts for presenting author's disclosure statement.
Learning Objectives: See individual abstracts
Moderator(s):Lynette Bradley, RPh, PhD
Organizer(s):Fred Mayer, MPH, RPh
11:30 AMIntroduction - Lynnette R. Bradley-Baker, PhD, RPh
11:35 AMNational and State Efforts to Expand Prescription Drug Coverage
11:36 AMUpdate: Congressional action on Medicare prescription drug benefit
John Hansen, MBA
11:53 AMState pharmacy assistance programs
David J Gross
12:10 PMPrescription Drug Outcome Management and Pricing Issues
12:11 PMCost containment of pharmaceutical issues under Medicare
Victor Freeman, MD
12:28 PMPrescription drug co-ops and cost containment
Ramon Castellblanch, PhD
12:45 PMState Acts to Establish Fairer Pricing for Prescription Drugs
12:46 PMMaine's Public Law 786 Update
Chellie Pingree
1:03 PMState-level actions on Rx drug affordability: benefits and pitfalls
Sidney J. Socolar, PhD
1:20 PMResearch Funding Issues in Prescription Drugs
1:21 PMPrescription drug marketing and research spending: The evidence does not support PhRMA's claims
Deborah Socolar, MPH
1:38 PMSolutions to Medicare and Prescription Drug Issues
1:39 PMPutting together a Medicare Prescription Drug Program: The Pharmacist's Perspective
Lucinda Maine, PhD
1:56 PMHCFA Standards of Practice for Pharmaceutical Care
Fred Mayer, RPh
2:13 PMRx for seniors: Dangers, deliverance and dollars
Cathy Cameron, RPh, MPH
2:30 PMCost of financing all needed medications for all Americans is surprisingly low, once drug makers' windfall profits are cut
Alan Sager, PhD
2:47 PMWhere Do We Go from Here? Putting the Pieces Together
2:48 PMQuestions, Answers, Open Discussion - Steven W. Schondelmeyer, PhD, PharmD
Sponsor:Alcohol, Tobacco, and Other Drugs
Cosponsors:Community Health Planning and Policy Development
CE Credits:CME, Chiropractic, Nursing, Pharmacy, Social Work

The 129th Annual Meeting of APHA